SENS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 19:03):

Stats
Šios dienos apimtis	527 787
Vidutinė apimtis	2.55M
Rinkos kapitalizacija	225.22M
EPS	$0 ( 2024-02-29 )
Kita pelno data	( $-0.0232 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.86
ATR14	$0.00100 (0.24%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-02	Prince Douglas S	Buy	15 931	Common Stock
2024-04-02	Fiorentino Edward	Buy	27 696	Common Stock
2024-04-02	Steven Edelman	Buy	25 245	Common Stock
2024-03-20	Hansen Brian B	Sell	2 619 048	Stock Option (Right to Buy)
2024-01-02	Defalco Stephen P	Buy	42 410	Common Stock

INSIDER POWER
5.84
Last 98 transactions
Buy: 13 341 086 \| Sell: 71 889 452

Tūris Koreliacija

Ilgas: -0.07 (neutral)

Trumpas: 0.79 (moderate)

Signal:(39.298) Neutral

Senseonics Holdings Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Senseonics Holdings Inc Koreliacija - Valiuta/Žaliavos

0.00
( neutral )

-0.11
( neutral )

0.00
( neutral )

-0.33
( neutral )

Senseonics Holdings Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$22.39M
Bruto pelnas:	$3.09M (13.81 %)
EPS:	$-0.110

FY	2023
Pajamos:	$22.39M
Bruto pelnas:	$3.09M (13.81 %)
EPS:	$-0.110

FY	2022
Pajamos:	$16.39M
Bruto pelnas:	$2.73M (16.63 %)
EPS:	$0.300

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.720

Financial Reports:

No articles found.

Senseonics Holdings Inc

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.